Correlation Between Aslan Pharmaceuticals and Structure Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aslan Pharmaceuticals and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aslan Pharmaceuticals and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aslan Pharmaceuticals and Structure Therapeutics American, you can compare the effects of market volatilities on Aslan Pharmaceuticals and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aslan Pharmaceuticals with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aslan Pharmaceuticals and Structure Therapeutics.

Diversification Opportunities for Aslan Pharmaceuticals and Structure Therapeutics

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aslan and Structure is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Aslan Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aslan Pharmaceuticals are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Aslan Pharmaceuticals i.e., Aslan Pharmaceuticals and Structure Therapeutics go up and down completely randomly.

Pair Corralation between Aslan Pharmaceuticals and Structure Therapeutics

If you would invest  60.00  in Aslan Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Aslan Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.76%
ValuesDaily Returns

Aslan Pharmaceuticals  vs.  Structure Therapeutics America

 Performance 
       Timeline  
Aslan Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aslan Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Aslan Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Structure Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Aslan Pharmaceuticals and Structure Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aslan Pharmaceuticals and Structure Therapeutics

The main advantage of trading using opposite Aslan Pharmaceuticals and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aslan Pharmaceuticals position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.
The idea behind Aslan Pharmaceuticals and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like